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Cardiovascular Topics
The effects of HIV/AIDS on the clinical profile and 
outcomes post pericardiectomy of patients with 
constrictive pericarditis: a retrospective review
DP Naidoo, G Laurence, B Sartorius, S Ponnusamy
Abstract
Objective: The clinical profile and surgical outcomes of 
patients with constrictive pericarditis were compared in 
HIV-positive and -negative individuals.
Methods: This study was a retrospective analysis of patients 
diagnosed with constrictive pericarditis at Inkosi Albert 
Luthuli Central Hospital, Durban, over a 10-year period 
(2004–2014).
Results: Of 83 patients with constrictive pericarditis, 32 
(38.1%) were HIV positive. Except for pericardial calcifica-
tion, which was more common in HIV-negative subjects (n 
= 15, 29.4% vs n = 2, 6.3%; p = 0.011), the clinical profile 
was similar in the two groups. Fourteen patients died pre-
operatively (16.9%) and three died peri-operatively (5.8%). 
On multivariable analysis, age (OR 1.17; 95% CI: 1.03–1.34; 
p = 0.02), serum albumin level (OR 0.63; 95% CI: 0.43–0.92; 
p = 0.016), gamma glutamyl transferase level (OR 0.97; 95% 
CI: 0.94–0.1.0; p = 0.034) and pulmonary artery pressure (OR 
1.49; 95% CI: 1.07–2.08; p = 0.018) emerged as independent 
predictors of pre-operative mortality rate. Peri-operative 
complications occurred more frequently in HIV-positive 
patients [9 (45%) vs 6 (17.6%); p = 0.030].
Conclusions: Without surgery, tuberculous constrictive peri-
carditis was associated with a high mortality rate. Although 
peri-operative complications occurred more frequently, 
surgery was not associated with increased mortality rates in 
HIV-positive subjects.
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Constrictive pericarditis remains an uncommon yet treatable 
cause of heart failure.1,2 The hallmark of constrictive pericarditis 
is impaired ventricular diastolic filling caused by a thickened, 
fibrosed pericardium, resulting in decreased stroke volume and 
varying degrees of systemic venous congestion.2-5 The natural 
history of this disorder remains unknown.6 
While medical therapy has been used to successfully 
treat patients with constriction in its early stages, surgical 
pericardiectomy remains the only treatment for chronic 
constrictive pericarditis.7,8 The surgical mortality rate remains 
high and has been reported to be between five and 14% in 
multiple large series.1,2,6,9-15 
Over the past two decades, there has been a changing spectrum 
of constrictive pericarditis in the developed world, with a declining 
incidence of infective aetiologies, in particular tuberculosis.1,3 
In sub-Saharan Africa, tuberculosis remains the dominant 
cause; about 30 to 60% of patients diagnosed with tuberculous 
pericarditis progress to constriction despite appropriate anti-
tuberculous therapy and adjunctive corticosteroids.16 
The effect of HIV on the incidence, natural history and 
surgical outcomes of patients with constrictive pericarditis has 
not been adequately documented.2 Recent data suggest that 
co-existing HIV infection may modify the clinical manifestations 
and natural history of tuberculous pericarditis and resultant 
constriction.17,18 Our study was designed to evaluate the clinical 
profile and surgical outcomes of HIV-positive and -negative 
patients with constrictive pericarditis. 
Methods
This study was a retrospective chart review of all patients 
referred to Inkosi Albert Luthuli Central Hospital in Durban, 
KwaZulu-Natal, for evaluation and management of suspected 
constrictive pericarditis during the period 2004–2014. Patients 
eligible for inclusion in the study constituted those in whom 
the diagnosis of constrictive pericarditis was confirmed using 
a combination of clinical symptoms and signs associated with 
typical echocardiographic and computer tomography (CT) scan 
findings. 
Clinical supporting features included peripheral oedema, 
ascites, pleural effusions, hepatomegaly, elevated jugular venous 
pressure and pericardial knock. Typical echocardiographic 
features of constriction were a thickened echogenic pericardium 
accompanied by paradoxical interventricular septal motion, and 
dilated non-compressible hepatic veins and inferior vena cava. 
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Thoracic CT scans were used to confirm pericardial thickening 
and calcification, and to demonstrate lymph node enlargement. 
Tuberculosis (TB) as the cause for constrictive pericarditis 
was inferred from a history of previous diagnosis of tuberculosis 
(pulmonary or extrapulmonary), or previous treatment for 
tuberculosis. Proven tuberculosis was defined by isolation of the 
organism or typical histological findings. Patients in whom the 
diagnosis of constrictive pericarditis was incorrect were excluded 
from the study population. 
Informed consent for HIV testing was obtained from all 
patients with suspected constriction who were referred to Inkosi 
Albert Luthuli Hospital with a view to surgical pericardiectomy. 
Relevant data (demographics, HIV status, clinical symptoms, 
signs and symptoms, and laboratory, echocardiographic, 
radiological and operative data) and follow-up findings were 
extracted. 
In the subset that underwent pericardiectomy, constrictive 
pericarditis was confirmed intra-operatively by identifying 
constrictive features with pericardial thickening and fibrosis. 
Surgery was performed by median sternotomy without 
cardiopulmonary bypass in all but one patient. At operation 
the entire ventricular epicardium, apex and diaphragmatic 
surface of the heart was freed. The pericardium was removed 
anteriorly extending laterally to the phrenic nerves and the 
posterior pericardium was left in situ after being freed from the 
epicardium. Any resection less than this was deemed a partial 
pericardiectomy. Immediate peri-operative mortality was defined 
as any death occurring during the index hospitalisation. 
The study was approved by the Biomedical Research Ethics 
Committee of the University of KwaZulu-Natal (BE 324/15).
Statistical analysis
Data were analysed using Stata 13.0 (StataCorp 2013, Stata 
Statistical Software: Release 13, College Station, TX: StataCorp 
LP). Continuous variables were summarised using mean 
and standard deviation or median and interquartile range. 
Differences in means of continuous predictors by HIV status 
(two groups) were assessed using the student’s t-test. If  the data 
were not normally distributed then the Kruskal–Wallis equality-
of-populations rank test  was employed instead. Association 
between HIV status and categorised explanatory variables/
risk factors were assessed using a Pearson chi-squared (χ2) test. 
Multivariate logistic regression was employed to estimate the 
Evaluated for CP
n = 86
Excluded, n = 3
• 2 patients did not have CP
• 1 patient’s HIV status was unknown
Confirmed CP with known HIV status
n = 83
HIV negative
n = 51 (62%)
HIV positive
n = 32 (39%)
Pericardiectomy
n = 16 (66.7%)
CD4 < 200 cells/mm3
n = 8 (15%)
CD4 > 200 cells/mm3
n = 24 (75%)
Pericardiectomy
n = 32 (62%)
Pericardiectomy
n = 5 (63%)
Did not undergo pericardiectomy
• 14 died pre-operatively
 –4 in hospital
 –10 out of hospital
• 15 still alive but lost to follow up
• 2 survival status unknown
Not followed up:
• 3 in-hospital peri-operative deaths
• 1 lost to follow up
• 6 referred back to base hospital f/u
Total undergoing pericardiectomy
n = 52 (63%)
Alive at 6/52 weeks’ follow up
n = 42
HIV positive CD4 < 200 cells/mm3
n = 4 (9.5%)
HIV positive CD4 > 200 cells/mm3
n = 12 (29%)
HIV negative
n = 26 (62%)
Fig. 1.  Early outcome of patients with constrictive pericarditis (CP).
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strength of association (odds ratios) between the explanatory 
predictors and HIV status. A p-value of < 0.05 was considered 
statistically significant.
Results
Pre-operative clinical profile
A total of 86 patients were eligible for inclusion during the 
study period (Fig. 1). Three patients were excluded, (incorrect 
diagnosis: n = 2, HIV status unknown: n = 1) leaving 83 (43 male, 
40 female) for analysis. The mean age of the total sample was 
37.98 ± 12.91 years (range 19–69). Of these patients, 32 (38.6%) 
were HIV positive, of whom 21 (65.6%) were on antiretroviral 
therapy, and of these, 19 (59%) patients were virally suppressed 
(viral load < 1 000 copies/ml). Three patients who were not on 
antiretroviral therapy had viral loads < 1 000 copies/ml. In total 
8/32 (25.0%) patients had a CD4 count of less than 200 cells/
mm3. The baseline characteristics stratified by HIV status are 
shown in Table 1.
The aetiology of constriction was tuberculosis in 80/83 
(96.3%) patients. Constriction was deemed to have followed 
viral pericarditis in two patients and the third developed 
constriction following repeated radio-ablation procedures for 
tachyarrhythmias. Tuberculosis was proven in 22 (26.5%) patients 
and was considered the probable aetiology in a further 58 (69.5%) 
patients. Although proven tuberculosis was identified more 
frequently in HIV-positive (40%) compared to HIV-negative 
patients (17.6%), this finding was not statistically significant. 
The mean body weight of HIV-positive patients was 5 kg less 
those who were HIV negative (62.77 ± 12.01 vs 67.69 ± 13.05 kg; 
p = 0.09) but this finding was also not statistically significant. 
Moderate dyspnoea (NYHA class II) was present in almost 
two-thirds (63.9%) of the patients and severe symptoms were 
present in 32.5% (NYHA class III and IV) of patients. Similarly, 
two-thirds (n = 57; 68.7%) of patients had ascites. There was no 
difference in the clinical characteristics between HIV-positive 
and -negative patients except for peripheral oedema, which 
was significantly more frequent in HIV-negative patients (86.2 
vs 65.6%; p = 0.026). Atrial fibrillation was documented in 
five patients (all HIV negative), four of whom had extensive 
pericardial calcification on chest radiography.
All patients (n = 83) had chest radiographs and echocardiograms 
and 77 (94%) had thoracic CT scans. A total of 17 patients 
(20.5%) had pericardial calcification on the chest radiograph 
and one additional patient had pericardial calcification identified 
on CT scan only. Extensive pericardial calcification was more 
common on the chest radiograph in HIV-negative compared 
to HIV-positive patients (n = 15, 29.4 vs n = 2, 6.3%; p = 
0.011). Mediastinal lymphadenopathy was identified in 47 (61%) 
patients and there was no difference between HIV-positive and 
-negative patients (p = 0.642)
On echocardiography, effusive constrictive pericarditis was 
found in seven (8.4%) patients, of whom four were HIV negative 
and three HIV positive. There was no significant difference in 
the ejection fraction (51.88 ± 7.5 vs 52.69 ± 4.96%; p = 0.593) 
and pulmonary arterial pressure (33.88 ± 8.86 vs 34.96 ± 7.76 
mmHg; p = 0.571) between HIV-negative and -positive patients, 
respectively. 
Laboratory data showed no significant differences in 
haemoglobin, white cell count, urea, creatinine and albumin 
Table 1. Baseline characteristics of study patients stratified by HIV status
Characteristics
All
(n = 83)
HIV negative
(n = 51)
HIV positive
(n = 32) p-valve
Age (years) 37.98 ± 12.91 38.82 ± 14.56 36.63 ± 14.56 0.454
Weight (kg) 65.75 ± 12.81 67.69 ± 13.05 62.77 ± 12.01 0.91
Gender 4.24
Male 43(51.8) 29 (56.9) 14 (43.75)
Female 40 (78.2 22 (43.1) 18 (56.35)
Aetiology of pericarditis 0.140
Probable tuberculosis 58 (69.9) 39 (76.5) 19 (59.4)
Proven tuberculosis 22 (26.5) 9 (17.6) 13 (40.6)
Other 3 (3.6) 3 (5.9) 0
NYHA functional class 0.481
l 3 (3.6) 2 (3.9) 1 (3.1)
ll 53 (63.9) 33 (64.7) 20 (62.5)
lll 22 (26.5) 4 (7.8) 1 (3.1)
lV 5 (6.0) 4 (7.8) 1 (3.1)
Examination
SBP (mmHg) 110.83 ± 11.85 110.78 ± 11.67 110.91 ± 12.32 0.963
DBP (mmHg) 70.57 ± 10.63 71.43 ± 9.86 69.19 ± 11.78 0.352
Pulse rate (beats/min) 88.76 ± 14.72 86.35 ± 14.74 92.59 ± 14.05 0.060
Jugular vv pressure 77 (92.8) 48 (94.1) 29 (90.6) 0.358
Pericardial knock 43 (51.8) 24 (47.1) 19 (59.4) 0.274
Hepatomegaly 76 (91.6) 46 (90.2) 30 (93.8) 0.767
Ascites 57 (68.7) 35 (68.3 22 (68.8) 0.991
Oedema 65 (78.3) 44 (86.2) 21 (65.6) 0.026
Chest X-ray
Pericardial calcifica-
tion
17 (20.5) 15 (29.2) 2 (6.3) 0.011
Pleural effusion 67 (80.7) 43 (84.3) 24 (75.0) 0.295
Echocardiography
Ejection fraction (%) 52.19 ± 6.61 51.88 ± 7.50 52.69 ± 4.96 0.593
End-diastolic dimen-
sion
47.95 ± 7.793 47.4 ± 7.92 48.81 ± 8.01 0.435
Left atrial size (mm) 43.85 ± 8.57 44.86 ± 9.5 42.28 ± 6.70 0.185
Septal bounce 81 (97.6) 49 (96.1) 32 (100.0) 0.257
PA pressure (mmHg) 34.31 ± 8.41 33.88 ± 8.86 34.96 ± 7.76 0.571
Dilated IVC/hepatic vv 73 (97.3) 45 (100.0) 28 (93.3) 0.157
CT chest 
Pleural effusion 58 (75.3) 37 (80.4) 21 (67.7) 0.282
Pericardial thickening 73 (94.8) 45 (97.8) 28 (90.3) 0.297
Pericardial calcification 18 (23.4) 15 (32.6) 3 (9.7) 0.032
Lymphadenopathy 47 (61.0) 27 (58.7) 20 (64.5) 0.64
Laboratory results: 
mean ± SD
Haemoglobin (g/dl) 12.78 ± 1.75 12.91 ± 1.76 12.58 ± 1.74 0.418
White cell count (109 
cells/l)
5.15 ± 1.47 5.25 ± 1.48 4.99 ± 1.46 0.444
Platelets (1012 cells/l) 251.86 ± 84.37 244.20 ± 79.82 264.06 ± 91.11 0.299
Sodium (mmol/l) 136.96 ± 3.33 137.27 ± 3.50 136.47 ± 3.03 0.286
Urea (mmol/l) 60.58 ± 2.57 6.40 ± 2.79 6.86 ± 2.20 0.286
Creatinine (µmol/l) 81.70 ± 20.57 81.76 ± 20.05 81.59 ± 21.55 0.971
Albumin (g/l) 37.60 ± 6.33 38.04 ± 5.99 36.91 ± 6.89 0.431
AST (U/l) 39.35 ± 13.59 37.22 ± 10.51 42.28 ± 16.69 0.110
ALT (U/l) 25.21 ± 16.94 20.71 ± 10.70 32 ± 22.06 0.002
Alkaline PO4 (U/l) 167.40 ± 89.50 146.02 ± 67.70 201 ± 108.82 0.005
Gamma GT (U/l) 249.16 ± 224.09 172.96 ± 104.76 370 ± 300.59 < 0.001
Data presented as mean ± standard deviation for continuous variables and n (%) 
for categorical variables. NYHA, New York Heart Association; SBP, systolic blood 
pressure; DBP, diastolic blood pressure; PA pressure, pulmonary artery pressure; 
IVC, inferior vena cava; CT, computed tomography; AST, aspartate aminotransfer-
ase; ALT, alanine aminotransferase; alkaline PO4, alkaline phosphatase; gamma GT, 
gamma glutamyl transferase. 
CT scanning was not undertaken in six subjects (five HIV-negative and one HIV-
positive subject). 
No results for dilated IVC and hepatic veins for eight subjects (six HIV-negative and 
two HIV-positive subjects).
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levels between HIV-negative and -positive patients. Of note, 
alkaline phosphatase (146.0 ± 67.7 vs 201.0 ± 108.8 U/l; p = 
0.005) and gamma glutamyl transferase (172.96 ± 104.76 vs 
370 ± 300 U/l; p ≤ 0.001) levels were significantly elevated in 
HIV-positive patients.
Pre-operative mortality rate
Of the initial study cohort of 83 patients with constrictive 
pericarditis, 31 (37.3%) patients did not undergo immediate 
pericardiectomy. Of these 31 subjects, four died in hospital 
shortly after admission (all HIV negative) from a low-cardiac-
output state, and the remaining 27 who were offered surgery 
did not return for the operation. Survival status of those lost to 
follow up was established telephonically as well as by checking 
the national registry of deaths. In this way it was established 
that a further 10 had died out of hospital (HIV positive: n = 4), 
yielding a total pre-operative mortality rate of 16.7% (14/83) 
(95% CI: 9.5–26.6%). 
Bivariate logistic regression analysis identified seven predictors 
of pre-operative mortality (Table 2). These were age (OR 1.11; 
95% CI: 1.04–1.18; p ≤ 0.001), levels of haemoglobin (OR 0.67; 
95% CI: 0.45–0.99; p = 0.031), albumin (OR 0.90; 95% CI: 
0.82–0.99; p = 0.019) and aspartate aminotransferase (OR 0.91; 
95% CI: 0.85–0.98; p = 0.003), and pulmonary artery pressure 
(OR 1.13; 95% CI: 1.05–1.22; p ≤ 0.001). HIV status had no 
influence on the pre-operative mortality rate (p = 0.693). 
On multivariable analysis, age (OR 1.17; 95% CI: 1.03–1.34; 
p = 0.02), serum albumin level (OR 0.63; 95% CI: 0.43–0.92; p 
= 0.016), gamma glutamyl transferase level (OR 0.97; 95% CI: 
0.94–0.1.0; p = 0.034) and pulmonary artery pressure (OR 1.49; 
95% CI: 1.07–2.08; p = 0.018) emerged as independent predictors 
of pre-operative mortality rate.
Operative outcome of patients undergoing peri-
cardiectomy
A total of 52 patients (62.7%) underwent pericardiectomy, 
which included 32 HIV-negative (61.54%) and 20 HIV-positive 
patients (38.5%). Of the 20 HIV-positive patients, 15 (75%) were 
on antiretroviral therapy with successful viral load suppression 
(< 1 000 copies/ml). Pericardial biopsy specimens taken at the 
time of surgery showed histological evidence of tuberculosis in 
the form of granulomas and/or acid-fast bacilli in 12/49 (24.5%) 
patients.
Complete pericardiectomy was achieved in 38 patients (73.1%) 
and there was no significant difference between HIV-positive and 
-negative patients (26%; 81.3 vs 12; 60%; p = 0.093). There were 
three in-hospital peri-operative deaths, yielding a peri-operative 
mortality rate of 5.7% (95% CI: 9.5–26.7%). One patient (HIV 
positive) died of intra-operative haemorrhage in theatre and 
two (HIV negative), who were both severely symptomatic 
pre-operatively (NYHA IV) with impaired ejection fraction, 
died in the intensive care unit (ICU) as a result of a low-cardiac-
output state in the ICU. There was no significant difference 
in the length of ICU stay between HIV-negative and -positive 
patients (4.28 ± 2.74 vs 5.11 ± 2.84 days; p = 0.321). 
Postoperative complications occurred in seven patients (9.6%), 
three of whom had also suffered intra-operative complications. 
These postoperative complications were: sternal wound sepsis 
(one), re-intubation for respiratory failure and tachyarrhythmia 
(one), thoracotomy for postoperative haemorrhage (one), 
postoperative renal impairment (one) and low-output cardiac 
failure (three). In total, peri-operative (intra- and post-operative) 
complications occurred more frequently in HIV-positive patients 
(HIV positive: 9, 45% vs HIV negative: 6, 17.6%; p = 0.030). The 
higher complication rate in HIV-positive patients could not be 
explained by left ventricular function since the left ventricular 
function was similarly preserved in both groups (HIV negative 
53.33 ± 6.7% vs HIV positive 53.93 ± 6.79%; p = 0.783). 
Of the 49 patients who were discharged (three died in 
hospital) after undergoing pericardiectomy, 41 (26 HIV positive) 
returned for the six-week postoperative follow up at our hospital. 
Six patients were followed up at their referral hospital and two 
were lost to follow up. Most patients improved their NYHA class 
by one or two levels (p < 0.001) (Fig. 2). The majority of patients 
had improved from NYHA class II to class I (n = 21, 50%) and 
NYHA class III to class I (n = 10, 23.8%). Eight patients showed 
no improvement in functional class. There was no significant 
difference in symptoms of dyspnoea (p = 1.000) or ejection 
fraction (p = 0.785) between HIV-positive and -negative patients.
Discussion
This study shows a relatively high rate of HIV infection 
(32/83, 38.6%) among patients with constrictive pericarditis 
compared to the 14.6% reported by Mutyaba et al.2 in a recent 
South African study, but less than the 12/19 (63%) reported by 
Abubaker and colleagues17 in a Nigerian study. These data for 
developing countries are in contrast to the very low rate reported 
by Gopaldas et al.18 in the USA, who found only 10 HIV-positive 
Table 2. Bivariate logistic regression model  
of associated pre-operative mortality
Characteristics Alive (n = 69)
Pre-operative 
death 
(n = 14)
Odds ratio 
(95% CI) p-value
Gender
Female 33 (47.8) 7 (50.0) 0.92 (0.29–2.89) 0.882
Male 36 (52.2) 7 (50.0)
HIV positive 0.693
CD4 > 200 cells/mm3 21 (30.4) 3 (21.4) 0.59 (0.15–2.36)
CD4 < 200 cells/mm3 7 (10.1) 1 (7.1) 0.59 (0.65–5.32)
NYHA class 69 (100) 14 (100) 1.50 (0.65–3.48) 0.351
Haemoglobin (g/dl) 12.96 ± 1.70 11.91 ± 1.78 0.67 (0.45–0.99) 0.031
White cell count (109 
cells/l)
5.17 ± 1.45 4.99 ± 1.58 0.91 (0.61–1.37) 0.660
Platelets (1012 cells/l) 257 ± 89.01 224.64 ± 49.96 0.99 (0.99–1.00) 0.160
Sodium (mmol/l) 137 ± 3.33 136 ± 3.28 0.91 (0.77–1.07) 0.243
Urea (mmol/l) 6.37± 2.17 7.6 ± 3.96 1.17 (0.96–1.42) 0.131
Creatinine (umol/l) 80.37 ± 20.87 88.21 ± 17.94 1.02 (0.99–1.04) 0.192
Albumin (g/l) 38.35 ± 6.29 33.93 ± 5.37 0.90 (0.82–0.99) 0.019
AST (U/l) 41.16 ± 13.71 31.36 ± 9.97 0.91 (0.85–0.98) 0.003
ALT (U/l) 25.87 ± 16.88 22 ± 17.52 0.98 (0.94–1.03) 0.403
Alkaline PO4 (U/l) 175.94 ± 93.06 125.29 ± 54.11 0.99 (0.98–1.00) 0.061
Gamma GT (U/l) 269.39 ± 235.30 149.43 ± 119.43 1.00 (0.99–1.00) 0.071
Ejection fraction (%) 51.97 ± 6.75 53.29 ± 6.06 1.03 (0.94–1.13) 0.491
PA pressure (mmHg) 32.80 ± 6.88 43 ± 11.19 1.13 (1.05–1.22) < 0.001
Data presented as mean ± standard deviation for continuous variables and n (%) 
for categorical variables. NYHA, New York Heart Association; CI, confidence 
interval; AST aspartate aminotransferase; ALT alanine aminotransferase; alka-
line PO4, alkaline phosphatase; gamma GT, gamma glutamyl transferase; PA 
pressure, pulmonary artery pressure.
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patients with constrictive pericarditis out of a sample size of 
3 847 undergoing pericardiectomy. 
In keeping with other studies from developing countries,2,11,12,19-21 
and in contrast to Western series,22,23 tuberculosis was the 
major aetiology of constrictive pericarditis in our study and 
highlights the impact of the HIV/AIDS epidemic in refuelling a 
resurgence of tuberculosis infections.24,25 Similar to other series,2,15 
proven tuberculosis (pericardial histology, culture of AFB from 
sputum, lymph nodes) was documented in 22 (26.5%) of the 
patients. In contrast to Reuter’s findings in TB pericarditis,26 we 
found histological evidence of definite tuberculosis in only nine 
operative pericardial biopsy specimens and could not determine 
from these small numbers whether histological evidence of 
tuberculosis is more common in HIV-positive subjects. The 
natural history of tuberculous pericarditis has been previously 
described, including treatment options to prevent progression to 
constriction.16,27-30 
In this study we found few differences in the clinical profile 
between HIV-positive and -negative patients. The higher levels 
of alkaline phosphatase and gamma glutamyl transferase among 
HIV-positive patients might have been due to hepatic tuberculosis 
or more likely to more severe hepatic congestion in these subjects. 
Importantly, there was no difference in the pre-operative and 
follow-up ejection fraction between HIV-positive and -negative 
patients. This finding differs from studies in patients with 
tuberculous pericarditis co-infected with HIV who have been 
found to have a higher prevalence of myopericarditis.27,31 
Preservation of ejection fraction might explain why we 
found no significant differences in peri-operative mortality 
rate observed between HIV-positive and -negative patients. It 
is also likely that antiretroviral therapy in our patients may 
have helped to preserve left ventricular function by preventing 
the development of opportunistic infections or HIV-associated 
myocardial dysfunction.
Pericardial calcification was identified on chest radiography 
in 17 (20.5%) of our study patients, which is much higher than 
the 5% reported by Strang et al. in the pre-HIV era.19 While 
equivalent rates of pericardial calcification in HIV-positive and 
-negative patients (21.4 vs 20.7%; p = 0.953) have been described 
in the study by Mutyaba et al.,2 we found that calcification was an 
uncommon finding in HIV-positive compared with HIV-negative 
patients (6.3 vs 29.4%; p = 0.011). Furthermore none of the eight 
patients with CD4 counts < 200 cells/mm3 developed pericardial 
calcification.
We attributed the higher prevalence of pericardial calcification 
among HIV-negative patients to longer survival in these patients 
with a more prolonged duration of infection, progressing to 
fibrosis and calcification. Alternatively it could be explained by 
the suppression of CD4 helper by the HI virus, leading to less 
fibrogenesis and calcification in these subjects.26
Among the 31 subjects who did not undergo early surgery, 
15 patients on telephonic contact were still alive, and of these, 
five reported improvement in their symptoms (survival status 
unknown in two) on anti-tuberculous therapy. Strang et al.32 
have shown that a significant number of patients diagnosed with 
tuberculous constrictive pericarditis may undergo resolution 
of  their symptoms on anti-tuberculous therapy. The high 
pre-operative mortality rate of 16.78% in our study emphasises the 
importance of pericardiectomy in ensuring a successful outcome 
in subjects who do not respond to anti-tuberculous therapy. 
Our analysis of the pre-operative outcome showed that 
HIV status had no effect on the pre-operative mortality rate 
in constrictive pericarditis in subjects on antiretroviral therapy. 
Instead, our analysis showed that older age, unsuppressed viral 
load, lower serum haemoglobin and albumin levels, as well as 
Six-week post-operative 
NYHA classPre-operative NYHA class
NYHA I
n = 3
NYHA I
n = 332
21
NYHA II
n = 9
NYHA II
n = 53
6
10
NYHA III
n = 22
NYHA III
n = 0
1
NYHA IV
n = 0
NYHA IV
n = 5
1
1
Fig. 2.  Comparison of pre-operative and six-week postop-
erative New York Heart Association functional class 
status in 41 patients (p < 0.0001). Most subjects 
improved by at least one functional class. NYHA, New 
York Heart Association.
Table 3. Operative characteristics of study patients stratified 
by HIV status
Characteristic All (n = 52)
HIV  
negative  
(n = 32)
HIV  
positive  
(n = 20) p-value
Pericardiectomy 0.093
Total 38 (73.1) 26 (81.3) 12 (60.0)
Sub-total 9 (17.3) 2 (6.3) 7 (35.0)
Not known 5 (9.6) 4 (12.5) 1 (5.0)
Inotrope usage 48 (94.1) 31 (96.9) 17(85.0) 0.547
Days in ICU 4.59 ± 2.84 4.28 ± 2.74 5.11 ± 2.84 0.321
Postoperative complications 15 (28.9) 6 (18.8) 9 (45.0) 0.030
Pericardial histology
Granulomas 9 (18.4) 4 (12.9) 5 (27.8) 0.259
Acid-fast bacilli 3 (6.1) 1 (3.2) 2 (11.1) 0.546
Calcification 12 (24.4) 10 (32.3) 2/18 (11.1) 0.168
Postoperative ejection 
fraction
53.55 ± 6.65 53.33 ± 6.70 53.93 ± 6.79 0.783
Postoperative six-week 
follow up
0.687
NYHA l 33 (80.4) 20 (76.9) 13 (86.7)
NYHA ll 9 (21.4) 6 (23.1) 2 (18.8)
Ejection fraction 53 ± 9.16 52.44 ± 11.50 53.83 ± 4.67 0.785
Data presented as mean ± standard deviation for continuous variables and n (%) 
for categorical variables. 
ICU, intensive care unit; NYHA, New York Heart Association. 
Details of inotrope usage was not available for one subject; three subjects’ 
histology results were not found (one HIV negative, two HIV positive); nine 
subjects did not have postoperative measurement of ejection fraction (four HIV-
negative subjects and five HIV-positive subjects); 41 patients attended six-week 
follow up (26 HIV negative, 15 HIV positive). Follow up ejection fraction (10 
HIV-negative, five HIV-positive patients).
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elevated pulmonary pressure were shown to predict pre-operative 
mortality rate. 
Similarly, we found no difference in the peri-operative and 
postoperative outcomes between HIV-positive and -negative 
patients. At the six-week follow-up visit, most patients in our 
series showed significant improvement in NYHA class (p ≤ 
0.001) (Table 3), with improvement of at least one functional 
class to NYHA I (78.6%) and II (21%). This finding is consistent 
with reports by Mutyaba et al.2 and Tetty et al.20 Furthermore, 
ejection fraction was preserved in both HIV-positive and 
-negative subjects. 
Although our in-hospital peri-operative mortality rate of 5.7% 
is higher than the 3.7% reported by Fennel et al.12 in the pre-HIV 
era, it is consistent with the majority of series worldwide.6,9,11-14,18 
It is much lower than the 14% mortality rate found by Mutyaba 
et al.2 in their series, possibly because our HIV-positive patients 
were virally suppressed on treatment. 
Peri-operative complications in our study appeared to be more 
common in HIV-positive patients undergoing pericardiectomy. 
Furthermore, complete pericardiectomy was less likely to be 
achieved in HIV-positive (n = 9, 50%) compared to -negative 
patients (n = 37, 71%). Whether this was due to the inflammatory 
process, with greater anatomical distortion making surgery more 
difficult, is not clear. 
Study limitations
Our study has limitations related to its retrospective design, 
including a number of patients who were lost to follow up 
while awaiting surgical pericardiectomy. We were able to obtain 
survival status in most patients and were able to show that a 
number of subjects died while awaiting surgery. Furthermore, 
long-term patient follow up was often not possible because many 
patients were from rural areas and had difficulty in accessing 
the clinic. Based on the available patient records we could only 
accurately comment on in-patient peri-operative mortality rate 
and the early six-week follow-up visit after surgery. Furthermore, 
in this study the diagnosis of constriction was made clinically and 
supported by echocardiographic findings. Although Doppler 
echocardiographic parameters (restrictive pattern) to confirm 
pericardial constriction were not measured, the diagnosis was 
confirmed in all subjects who underwent surgery for pericardial 
constriction. 
Conclusion 
The findings of this study have important clinical implications. 
Without surgery, constrictive pericarditis is associated with a 
high mortality rate. Our study emphasises the benefits of surgery 
in patients who do not respond to anti-tuberculous therapy. 
Over a third of patients with constriction are HIV-positive in a 
developing country. Although HIV infection is associated with 
a higher in-hospital complication rate, peri-operative mortality 
rate is unaffected in subjects who are on antiretroviral treatment 
and are virologically suppressed. 
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